SMC - March 2025 decisions

10 March 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

February 2025 decisions

10 February 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

Santhera’s Duchenne muscular dystrophy drug Agamree accepted by SMC

16 January 2025 - The rare muscle wasting disorder affects approximately 2,500 males in the UK at any one time. ...

Read more →

January 2025 decisions

13 January 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

December 2024 decisions

9 December 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

November 2024 decisions

11 November 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

October 2024 decisions

7 October 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - September 2024 decisions

9 September 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - August 2024 decisions

12 August 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - July 2024 decisions

 8 July 2024 - Voretigene neparvovec (Luxturna) was accepted for the treatment of adults and children with an extremely rare inherited ...

Read more →

SMC - June 2024 decisions

10 June 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - May 2024 decisions

13 May 2024 - The SMC has today published advice on two medicines. ...

Read more →

NICE issues final draft guidance for use of remdesivir and also for tixagevimab-cilgavimab (Evusheld) for treatment of COVID-19

9 April 2024 - Final draft guidance for remdesivir and for tixagevimab with cilgavimab has been published by NICE. ...

Read more →

SMC - April 2024 decisions

8 April 2024 - The SMC has today published advice on seven medicines. ...

Read more →

SMC - March 2024 decisions

11 March 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...

Read more →